Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 23-Mar-22 4:43 PM View:  | Passage Bio, Inc. (PASG) | 21-Mar-22 | Private Purchase | 10,000 | $3.15 | $31,500.00 | 167% 5.98K to 15.98K | |
| 21-May-21 6:05 PM View: | Passage Bio, Inc. (PASG) | 21-May-21 | Market Purchase | 2,000 | $13.11 | $26,230.00 | 50% 3.98K to 5.98K | |
| 03-Mar-20 6:40 PM View: | Passage Bio, Inc. (PASG) | 03-Mar-20 | Purchase | 1,100 | $18.00 | $19,800.00 | 100% 0 to 1.1K | |
| 05-Sep-12 4:46 PM View: | Allos Therapeutics, Inc. (ALTH) | 04-Sep-12 | Disposition (change in control) | 346,933 | $1.82 | $631,418.00 | (100%) 346.93K to 0 | (< 1%) |
| 01-Mar-12 6:14 PM View: | Allos Therapeutics, Inc. (ALTH) | 01-Mar-12 | Market Sale (Planned) | 4,473 | $1.50 | $6,690.27 | (1%) 351.41K to 346.93K | 2% |
| 01-Mar-12 6:14 PM View: | Allos Therapeutics, Inc. (ALTH) | 29-Feb-12 | Market Sale (Planned) | 4,505 | $1.52 | $6,869.22 | (1%) 355.91K to 351.41K | 4% |
| 01-Mar-12 6:14 PM View: | Allos Therapeutics, Inc. (ALTH) | 28-Feb-12 | Grant | 179,727 | -- | -- | 102% 176.18K to 355.91K | |
| 27-Feb-12 5:43 PM View: | Allos Therapeutics, Inc. (ALTH) | 24-Feb-12 | Market Sale (Planned) | 575 | $1.54 | $888.09 | (< 1%) 176.76K to 176.18K | (2%) |
| 27-Feb-12 5:43 PM View: | Allos Therapeutics, Inc. (ALTH) | 23-Feb-12 | Market Sale (Planned) | 2,500 | $1.58 | $3,958.00 | (1%) 179.26K to 176.76K | < 1% |
| 17-Nov-11 5:03 PM View: | Allos Therapeutics, Inc. (ALTH) | 16-Nov-11 | Market Sale (Planned) | 300 | $1.43 | $429.51 | (< 1%) 179.56K to 179.26K | |
| 17-Nov-11 5:03 PM View: | Allos Therapeutics, Inc. (ALTH) | 15-Nov-11 | Market Sale (Planned) | 12,465 | $1.44 | $18,008.20 | (6%) 192.02K to 179.56K | |
| 02-Mar-11 5:07 PM View: | Allos Therapeutics, Inc. (ALTH) | 28-Feb-11 | Grant | 67,298 | -- | -- | 54% 124.73K to 192.02K | |
| 25-Feb-11 5:25 PM View: | Allos Therapeutics, Inc. (ALTH) | 24-Feb-11 | Market Sale (Planned) | 507 | $3.12 | $1,582.60 | (< 1%) 125.23K to 124.73K | (3%) |
| 25-Feb-11 5:25 PM View: | Allos Therapeutics, Inc. (ALTH) | 23-Feb-11 | Market Sale (Planned) | 2,250 | $3.25 | $7,312.50 | (2%) 127.48K to 125.23K | 1% |
| 22-Oct-10 5:16 PM View: | Allos Therapeutics, Inc. (ALTH) | 20-Oct-10 | Grant | 100,671 | -- | -- | 375% 26.81K to 127.48K |